Independence Realty Trust vs National Health Investors
IRT and NHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IRT and NHI compare
Independence Realty Trust and National Health Investors are about the same size, with market caps of $3.5B and $3.3B.
On earnings, National Health Investors is cheaper: it trades at 19.4× trailing earnings, against 81.8× for Independence Realty Trust.
National Health Investors grew revenue faster over the last twelve months (23.9% versus 3.5% for Independence Realty Trust).
National Health Investors keeps more of each dollar of sales as profit, with a net margin of 38.6% compared with 6.5% at Independence Realty Trust.
Both pay dividends: Independence Realty Trust yields 4.8% and National Health Investors 5.5%.
National Health Investors scores higher on the StockData Score (14 against 6 for Independence Realty Trust), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IRT | NHI |
|---|---|---|
| Size and price | ||
| Market cap | $3.5B | $3.3B |
| Share price | $14.72 | $67.04 |
| Change, 1 year | −2.6% | −8.9% |
| Change, 5 years | −39.9% | 20.9% |
| Beta (5Y) | 0.82 | 0.38 |
| Employees | 904 | 32 |
| StockData Score | ||
| Total score | 6 | 14 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 1 | 5 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 0 | 0 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 81.8× | 19.4× (better) |
| P/S | 5.2× (better) | 7.6× |
| P/B | 1.0× (better) | 2.1× |
| PEG | – | 0.72 |
| Fair value | $10.46 | $69.56 |
| Margin of safety | −40.8% | 3.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.5% | 23.9% (better) |
| Revenue growth, 5Y average | 25.4% (better) | 2.5% |
| Net income growth (TTM) | 56.6% (better) | 16.7% |
| EPS growth (TTM) | 50.0% (better) | 10.5% |
| EPS growth, 5Y average | 8.4% (better) | −6.1% |
| Profitability | ||
| Net margin | 6.5% | 38.6% (better) |
| Return on equity | 1.3% | 10.9% (better) |
| Financial health | ||
| Altman Z-score | 0.76 | 2.93 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 4.8% | 5.5% (better) |
| Payout ratio | 370% | 105% |
| Years of dividend growth | 4 (better) | 1 |
| Dividend growth, 5Y average | 4.4% (better) | −4.6% |
| Buyback yield | – | −3.1% |
| Shareholder yield | 4.8% (better) | 2.4% |
| Ownership | ||
| Held by institutions | 99.0% | 77.7% |
| Held by insiders | 0.79% | 2.5% |
| Insider net buying, 12 months | −$90.1K | $167K (better) |
| Short interest, % of float | 8.2% | 5.0% |
Go deeper
- IRT stock overview
- IRT income statement
- IRT valuation and score
- NHI stock overview
- NHI income statement
- NHI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.